Private company
GENETHERA INC
American biological products company, incorporated in Nevada1
In its 2022 annual report the company says: “We are a biotechnology company dedicated to eradicating zoonotic diseases such as COVID-19 (Novel Coronavirus), Paratuberculosis (Johne’s disease), Mad Cow Disease, Chronic Wasting Disease, and E.coli and Salmonella infections, by applying our advanced proprietary molecular sciences and technologies.”17 It is headquartered in Westminster, Colorado.1
Last updated Oct 21, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating expenses | $1.0M7 | |||||||
| Operating income | -$680.1K3 | -$605.7K3 | -$605.7K4 | -$3.9M5 | -$739.2K6 | -$740.6K7 | -$1.0M7 | |
| Interest | -$184.6K8 | -$137.7K8 | $146.6K4 | $118.0K5 | $28.6K6 | $33.9K7 | $2.2K7 | |
| Income before tax | -$1.0M7 | |||||||
| Income tax | $03 | $03 | $07 | $07 | ||||
| Net income | -$1.1M8 | -$778.9K8 | -$757.7K4 | -$3.4M5 | -$517.7K6 | -$774.5K7 | -$1.0M7 | |
| Earnings per share | -$0.038 | -$0.028 | -$0.047 | -$0.047 | ||||
| Earnings per share (diluted) | -$0.038 | -$0.028 | ||||||
| Shares (weighted, basic) | 25.4M shares7 |
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Cash | $03 | $03 | $167.7K3 | $5.3K7 | $07 | $07 | ||
| Current assets | $22.5K8 | $03 | $167.7K4 | $5.0K5 | $5.3K6 | $1.0K7 | $1.0K7 | |
| Property, plant and equipment | $5.3K7 | |||||||
| Total assets | $146.1K8 | $03 | $206.1K4 | $38.2K5 | $21.1K6 | $11.6K7 | $6.3K7 | |
| Accounts payable | $81.1K7 | |||||||
| Current liabilities | $6.7M8 | $7.1M8 | $7.4M4 | $6.4M5 | $6.9M6 | $7.7M6 | ||
| Total liabilities | $6.7M8 | $7.1M3 | $7.4M4 | $6.4M5 | $6.9M6 | $7.7M7 | $8.2M7 | |
| Retained earnings | -$32.3M7 | |||||||
| Shareholders’ equity | -$6.5M8 | -$7.1M4 | -$7.2M5 | -$6.4M6 | -$6.9M7 | -$7.7M7 | -$8.2M7 | |
| Shares outstanding | 36.6M shares8 | 40.1M shares8 | 40.1M shares3 | 35.9M shares5 | 35.9M shares6 | 24.1M shares7 | 34.1M shares7 | 34.1M shares7 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
What it owns
What GENETHERA INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
Leadership
Who has led GENETHERA INC, and when. Pick a name to see everywhere that person has worked.
Chief executive
Chair
Chief financial officer
- Chief executive officerAntonio Milici Jan 4, 2012 to Jan 5, 201212
- ChairAntonio Milici Jan 4, 2012 to Jan 5, 201212
- Chief financial officerSteven Michael Grubner Apr 7, 2006 to Apr 10, 200613
Board members and other officers (2)
- Chief Administrative OfficerTannya L. Irizarry Jan 5, 2012 to Jan 5, 201214
- Board memberAvel Kolesnikov Jan 9, 2012 to Jan 9, 201215
Former names
- HAND BRAND DISTRIBUTION INCSep 9, 1999 to Nov 21, 20032
Timeline
Filings
14 filings to the SEC since October 2021: 2 annual reports, 4 quarterly reports, 1 major events, 7 other. The latest 14:
- Mar 11, 2025REVOKED EDGAR
- Mar 31, 2023NT 10-K EDGAR
- Mar 2, 2023UPLOAD EDGAR
- Feb 1, 202310-K/A EDGAR
- Dec 27, 2022UPLOAD EDGAR
- Nov 14, 202210-Q EDGAR
- Aug 18, 202210-Q EDGAR
- Aug 12, 2022NT 10-Q EDGAR
- May 18, 202210-Q EDGAR
- May 13, 2022NT 10-Q EDGAR
- Apr 14, 202210-K EDGAR
- Mar 31, 2022NT 10-K EDGAR
- Nov 15, 202110-Q EDGAR
- Oct 12, 20218-K EDGAR
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
SEC filer profile
How GENETHERA INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARGENETHERA INC1
- CIK0001017110
- Employer ID (EIN)65-06224631
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Incorporated inNevada1
- Fiscal year endsDecember 311
- Industry code (SIC)2836 Biological Products, (No Diagnostic Substances)1
- SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
- Business address3051 W 105Th Avenue, Unit 350251, Westminster, CO 800311
- Phone720-587-51001
- Shares outstanding35,333,319 as of Nov 14, 202211
- Public float$620.3K as of Jun 30, 20217
- On EDGAR sinceSep 3, 19991
- Filings357 in all: 8-K (49), 10-Q (44), NT 10-Q (33), UPLOAD (23), 10QSB (22), NT 10-K (17), 10-K (16), CORRESP (14)1
All 45 form types
10-Q/A (13), 8-K/A (11), 10KSB/A (10), 4 (10), 10QSB/A (8), 3 (8), SB-2/A (8), SC 13G/A (8), 10-K/A (7), 10KSB (6), S-8 (6), 10SB12G/A (4), PRE 14C (4), 4/A (3), SB-2 (3), 3/A (2), 424B3 (2), DEF 14C (2), NT 10-Q/A (2), NTN 10K (2), NTN 10Q (2), REGDEX (2), SC 13G (2), 10KSB40 (1), 10SB12G (1), 144 (1), D (1), DEFR14C (1), EFFECT (1), NT-NSAR (1), PREM14C (1), PRER14C (1), REVOKED (1), RW WD (1), S-8 POS (1), SC 13D (1), SC 13D/A (1)
- Latest filingsAnnual report (10-K) Apr 14, 2022
Quarterly report (10-Q) Nov 14, 2022
Latest 8-K (8-K) Oct 12, 2021
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARGENETHERA INC filings on SEC EDGAR
- 2SEC EDGARGENETHERA INC filings on SEC EDGAR
- 3SEC EDGARGENETHERA INC 10-K for fiscal 2015
- 4SEC EDGARGENETHERA INC 10-K for fiscal 2017
- 5SEC EDGARGENETHERA INC 10-K for fiscal 2018
- 6SEC EDGARGENETHERA INC 10-K for fiscal 2019
- 7SEC EDGARGENETHERA INC 10-K for fiscal 2020
- 8SEC EDGARGENETHERA INC 10-K for fiscal 2015
- 9SEC EDGARGENETHERA INC 10-Q for fiscal 2022
- 10SEC EDGARGENETHERA INC 10-Q for fiscal 2022
- 11SEC EDGARGENETHERA INC 10-Q for fiscal 2022
- 12
- 13
- 14
- 15SEC EDGARAvel Kolesnikov, Board member
- 16SEC EDGAREntered a material agreement
- 17SEC EDGARGENETHERA INC filing with the SEC